Supernus Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.

About SUPN

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. 

CEO
Jack A. Khattar
CEOJack A. Khattar
Employees
778
Employees778
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
2005
Founded2005
Employees
778
Employees778

SUPN Key Statistics

Market cap
2.68B
Market cap2.68B
Price-Earnings ratio
-90.21
Price-Earnings ratio-90.21
Dividend yield
Dividend yield
Average volume
580.52K
Average volume580.52K
High today
$47.14
High today$47.14
Low today
$45.96
Low today$45.96
Open price
$46.60
Open price$46.60
Volume
485.97K
Volume485.97K
52 Week high
$59.68
52 Week high$59.68
52 Week low
$30.83
52 Week low$30.83

Stock Snapshot

With a market cap of 2.68B, Supernus Pharmaceuticals(SUPN) trades at $46.18. The stock has a price-to-earnings ratio of -90.21.

On 2026-05-30, Supernus Pharmaceuticals(SUPN) stock traded between a low of $45.96 and a high of $47.14. Shares are currently priced at $46.18, which is +0.5% above the low and -2.0% below the high.

The Supernus Pharmaceuticals(SUPN)'s current trading volume is 485.97K, compared to an average daily volume of 580.52K.

During the past year, Supernus Pharmaceuticals(SUPN) stock moved between $30.83 at its lowest and $59.68 at its peak.

During the past year, Supernus Pharmaceuticals(SUPN) stock moved between $30.83 at its lowest and $59.68 at its peak.

SUPN News

Simply Wall St 4d
Assessing Supernus Pharmaceuticals Valuation After Recent Share Price Weakness And Pipeline Progress

Advertisement Recent performance context for Supernus Pharmaceuticals Without a single headline event driving attention today, Supernus Pharmaceuticals (SUPN)...

Assessing Supernus Pharmaceuticals Valuation After Recent Share Price Weakness And Pipeline Progress

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

People also own

Based on the portfolios of people who own SUPN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.